Alembic Pharmaceuticals Ltd receives EIR from USFDA for API-III facility at Karakhadi

Alembic Pharmaceuticals Limited has received an Establishment Inspection Report (EIR) from the US Food and Drug Administration (US FDA) for the inspection carried out by them at our API-III Facility at Karakhadi from 17th March, 2025 to 21st March, 2025.

Shares of Alembic Pharmaceuticals Limited was last trading in BSE at Rs. 970.25 as compared to the previous close of Rs. 970.15. The total number of shares traded during the day was 9885 in over 332 trades.

The stock hit an intraday high of Rs. 979.25 and intraday low of 962.50. The net turnover during the day was Rs. 9602073.00.

Source : Equity Bulls

Keywords

AlembicPharmaceuticals INE901L01018 USFDA EIR API3Facility Karakhadi